Photo of Kinjal Sharma

Associate in the Disputes Resolution Practice at the Mumbai office of Cyril Amarchand Mangaldas. Kinjal can be reached at  kinjal.sharma@cyrilshroff.com.

U.S. Spotlight on Pharma Imports: What does this mean for Indian Pharma?

The U.S. Department of Commerce Bureau of Industry and Security (“BIS”), on April 14, 2025, announced the initiation of an investigation into the imports of pharmaceuticals and pharmaceutical ingredients as well as semiconductors and semiconductor manufacturing equipment in the context of U.S. national security. This move could affect India’s USD 10 billion annual pharmaceutical exports to the U.S.Continue Reading U.S. Spotlight on Pharma Imports: What does this mean for Indian Pharma?

FCPA, FCA and the Trump Effect: What Indian companies need to know

The Foreign Corrupt Practices Act (“FCPA”) and the False Claims Act (“FCA”) are two pivotal legislations of the United States (“U.S.”) that significantly influence the operations of multinational corporations, including Indian entities. The most notable recent cases against Indian companies are: (i) the allegations on the Adani Group for orchestrating a bribery scheme thereby violating the FCA; and (ii) investigation of Azure Power Global on the allegations of improper payments and misrepresentation of the company’s anti-bribery practices to gain U.S. financing in violation of the FCPA.Continue Reading FCPA, FCA and the Trump Effect: What Indian companies need to know

US-India discussion on Sanctions: Indian Companies to remain diligent about Sanctions Compliance

Recent actions: Russia-related sanctions

On October 30, 2024, the United States (“US”) Department of Treasury’s Office of Foreign Asset Control (“OFAC”) sanctioned 19 Indian companies and 2 Indian individuals under its Russia-related sanctions program under the Executive Order (“EO”) 14024. This action was in the nature of imposition of secondary sanctions on third-country actors to discourage non-US persons from engaging in certain transactions, even without a US nexus, that might be harmful to the objectives of the US sanctions programs.Continue Reading US-India discussion on Sanctions: Indian Companies to remain diligent about Sanctions Compliance

Ripple Effect of Sanctions- II: Recent Iran-related sanctions imposed by the United States

Background

In the previous blog published on November 19, 2024, we had discussed the United States (“US”) Office of foreign Asset Control (“OFAC”) sanctioning nearly 400 entities and individuals for their contribution to Russia’s efforts against Ukraine and the implications of this action on Indian businesses. The US has since imposed sanctions on several entities under its Russia-related sanctions program as well as under its other sanctions programs. There has also been a major focus on the Iran-related sanctions program.Continue Reading Ripple Effect of Sanctions- II: Recent Iran-related sanctions imposed by the United States